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Summary.-A variant subline (B16-F10-B2) selected from the B16-F1O melanoma
cell line, shows greater metastatic capacity and preferential growth in the brain after
i.v. injection into C57BL/6 mice. Several biological properties of these two cell lines
have been compared, in an an effort to determine the mechanisms responsible for
this non-random metastatic pattern. No differences in cell morphology, in vitro
growth rates or exposed cell-surface proteins were detected. Quantitative analysis
of tumour-cell arrest and distribution using 125IUdR-labelled cells indicated that,
although initial arrest patterns of the cell lines were very similar, B16-F10-B2 cells
survived in the lungs to a greater extent than B16-FlO cells. Karyotype analysis
revealed that the B16-F10-B2 cell line had a higher mean number of chromosomes
than the parent line, whereas the variance of chromosome distribution was less. We
suggest that the selection of a brain-colonizing variant represents the emergence of
a pre-existing subpopulation of cells, and provides a useful model for studying
mechanisms of intracranial metastasis.
INTRACRANIAL METASTASES are a fre-
quent complication of systemic cancer. It
has been reported that 16-5% of patients
with generalized neoplastic disease have
intracranial metastases at necropsy (Aron-
son et al., 1964). Of patients afflicted with
tumours such as malignant melanoma, the
percentage affected by secondary brain
tumours can be as high as 50-60%
(Aronson et al., 1964; Posner & Shapiro,
1975; Posner, 1974; Patel et al., 1 978). The
effect of tumour development in the cen-
tral nervous system (CNS) can be particu-
larly devastating, since most patients
develop major neurological symptoms that
are both physically and psychologically
debilitating (Posner & Shapiro, 1975).
Survival after the development of cerebral
metastases is rare, and treatment is
generally unsuccessful in spite of increas-
ingly aggressive therapeutic interventions
(Posner, 1974; Posner & Shapiro, 1975).
The difficulty in developing effective
therapeutic modalities for intracranial
metastases is in part due to a lack of
suitable experimental models ofmetastatic
brain tumours (Conley, 1979). In deter-
mining therapeutic regimens, the value
of results from experimental animal sys-
tems depends on the use of a biologically
appropriate model (Fidler, 1978). There
would appear then to be a need for a suit-
able model for intracranial metastasis.
The induction of rodent brain tumours
by direct intracranial inoculation of
tumour cells (Conley & Remington, 1977;
Ausman et al., 1970; Gershbein et al., 1975)
or virus particles (Rabson et al., 1974;
Roseman et al., 1978; Yung et al., 1975)
circumvents the need for tumour cells to
cross the blood-brain barrier, as they must
do in the clinical situation. The use of
intracarotid (Ushio et al., 1977) or intra-
cardiac (Conley, 1979) injections oftumour
cells has produced experimental brain
metastases in rodents, but these techniques
require greater dexterity and technical
ability than the more simple i.v. injection.
Malignant melanoma in man dissemin-
ates predominantly to both the lungs andA. RAZ AND I. R. HART
the brain (Patel et al., 1978). A brain-
seeking variant line has been isolated from
a murine B16 melanoma, but its propensity
for the CNS appeared to be at the expense
of its lung-colonizing ability (Brunson et
al, 1978). In our laboratory we are in-
vestigating certain aspects of the biology
of metastasis, using the BI 6 melanoma
syngeneic to C57BL/6 mice, which does
not growr routinely in the brains of mice
after i.v. inoculation. During a recent
study we observed that, if Bl6-F1 0
melanoma cells were treated with cyto-
skeleton-disrupting druigs before injecting
them into mice, altered metastatic patterns
were produced (Hart & Fidler, 1980). In
the present study we report how we have
used this fact to select for a highly malig-
nant variant of the B16 melanoma that
will produce both lung and brain tumours
in mice after i.v. injection of tumour-cell
suspi nsions. This cell line very closely
iniiniics the behaviour of human tumours,
an1,11d s,hould serve as a uiseful animal model
for the study of brain metastasis.
MATERIALS AND METHODS
Mico.-Male C57BL/6 mice aged 6-8
X-eeks wrere obtained from the Animal Pro-
duction Area of the Frederick Cancer Re-
search Ceniter.
Cell lines.-The original tumour line was
the B16-F10 melanoma, syngeneic to the
C57BL/6 mouse, selected by Fidler (1973) for
its considerable ability to colonize to the
lung. Tumour cells were grow n in Falcon
tissue-culture flasks writh Eagle's minimum
essential medium (EMEM) as described pre-
viously (Fidler, 1974). The tumour cell lines
were tested for and found free ofmycoplasma
and the following murine viruses: reovirus
Type 3, pneumonia virus of mice, K virus,
Tlieiler-s encephalitis virus. Sendai virus,
minute virus of mice, mouse adenovirus.
mouse hepatitis virus, lymphocytic chorio-
meningitis virus, ectromelia virus and lactate
dehydrogenase virus (Microbiological Asso-
ciates, MWalkersville, MD).
For in vivo studies the tumour cells were
harve.4ted from subconfluent cultures in ex-
ponential growth by overlaying the cells with
a thin layer of 0-25% trypsin-0 020% EDTA
for 2 min. The cells were then washed and
resuspended in Hanks' balanced salt solution
(HBSS). Tumour-cell viability was assessed
by trypan-blue exclusion, and only suspen-
sions with single cells of viability >9500 were
used in these studies.
Selection of brain-colonizing variant.-B16-
FIO tumour cells wvere harvested as described
above and their number was adjusted to
2-5 x 105 single viable cells/ml HBSS. The cell
suspension was then treated with cyto-
chalasin B (CB, Calbiochem, San Diego, CA)
dissolved in dimethyl sulphoxide (5 mg/ml)
and colchicine (Sigma Chemical Co., St
Louis, MO) to give a final concentration of
10 Mg CB/ml in 5 x 10-5M colchicine. First the
suspension was incubated at 22°C for 30 min,
and then agitated with a Pasteur pipette;
0-2ml volumes (5 x 104 cells) were injected
into 5 mice via the tail vein. The viability of
the injected cells was >95%o as assessed by
trypan-blue exclusion.
Three weeks after the i.v. injection, the
mice were killed and necropsied. Three of the
5 miee had small, black melanotic tumours in
the dorsal cerebrum. A single tumour nodule
was excised in a sterile manner from one of
the brains and subjected to tissue-culture
conditions as described above. The tumour
cell line that developed and grew from these
lesions was designated B16-F1O-B1. When
the cells were in exponential growth they
were harvested as described above, adjusted
to 2-5 x 105 cells/ml and 0-2ml volumes were
injected by intracardiac (via the left ven-
tricle) or by i.v. routes. Ten mice from each
group were inoculated. Cells recovered from
a solitary tumour nodule in the brain of one
mouse 3 weeks after intracardiac injection
wvere harvested and grown exactly as de-
scribed above and the cell line was designated
B16-F1O-B2.
Tumour-cell dissemination and growth after
i.v. injection. Melanoma cells were Ihar-
vested, adjusted and injected via the tail vein
as described above. Mice wvere killed 21 days
later and necropsied; extrapulmonary tu-
mours were noted and, with the aid of a
dissecting microscope, pulmonary nodules
were counted after rinsing of the lungs with
wvater.
Quantitative analysis of tumour-cell arrest
and survival. Mice were injected i.v. via the
tail vein with tumour cells prelabelled in
vitro with 1251-iododeoxyuridine (125IUdR).
Tumour-cell DNA was labelled by the addi-
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tion of 0-2 ltCi '25IUdR (sp. act. 200 mCi/
mmol)/ml medium to cultures in exponential
growth for 24 h. The cells were harvested,
washed twice with HBSS and adjusted to
2-5 x 105 cells/ml and 0-2ml aliquots were
injected into mice.
Three representative inocula from eaclh cell
suspension were placed into vials and
monitored for radioactivity in a well-type
Nal crystal scintillation counter to determine
activity per cell. At 10, 60, 120 min and 1 day
after i.v. injection, 5 mice from each group
were killed. Lungs, liver, spleen and 0-2 ml of
blood were collected from each animal. The
head was amputated and the lower jaw re-
moved to elimninate the thyroid; the cranium
-was then treated in the same way as other
organs. The organs were placed in 7000
ethanol, which was replaced twice in the next
2 days to remove ethanol-soluble 1251. The
residual ethanol-insoluble radioactivity was
considered to be associated writh tumour cells
viable at the time of organ removal (Fidler,
1970).
Karyotype. Karyotypes of the parent
B16-F1O and the selected brain-colonizing
lines -were prepared by conventional tech-
niques. The cells were accumulated in meta-
phase by the addition of 1 ,ug/ml colcemid for
3 h at 37°C. The cells were theii harvested
from the substrate with 02%o trypsin and
washed in phosphate-buffered saline (PBS).
The cell pellet was resuspended in 5 ml 0-075M
KCI for 30 min at room temperature (23°C)
and the cells then fixed by the addition of an
equal volume of fresh fixative (3:1 methanol:
acetic acid). Fixed cells wNere dropped on to
ice-cold wet microscope slides, dried on a
warm plate and stained with Giemnsa solution.
In vitro growth curves. Tumour cells from
each line were plated at a density of 3 x 105/
60mm dish ill EMEM. Cultures wereincubated
at 37°C in 500 C02 in an humidified atmos-
phere. Triplicate samples were terminated 24,
48, 72 and 96 h after plating; cells -were har-
vested with 0 2% trypsin-002%o EDTA and
counted in a Coulter counter, Model 2B1
(Coulter Electronics Inc., Hialeah, FL).
Light mticroscolpy. Melanoma cells from the
tumour lines -were cultivated on glass cover-
slips. Thie cells were fixed in 2-5%o glutar-
aldehyde in PBS for 30 min at 22°C and the
coverslips were mounted on glass microscope
slides before examination. A Karl Zeiss
microscope equipped with polarizing optics
(Nomarski) was used for photography.
23
Brain tissue from animals with grossly
obvious brain metastases was fixed in 10%
buffered formal saline for 24 h, processed and
embedded in paraffin wrax. Sections were cut
at 5 vum and stained by Ehrlich's haematoxy-
lin and eosin (H & E).
Labelling of cell-surface proteins.-Tumour
cell-surface membrane proteins were radio-
iodinated using a lactoperoxidase-catalysed
iodination technique of Marchalonis et al.
(1971). The cell-surface radiolabelled proteins
were resolved by separation using sodium
dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) (Laemmli, 1970).
RESULTS
Selection of a brain-colonizing variant
The treatment of B16-F1O tumour cells
with CB plus colchicine before their i.v.
injection into mice, led to the formation of
intracranial metastases. Cells recovered
from the cerebral lesions and cultured in
vitro were designated B16-F1O-Bl. Injec-
tion of 5 x 104 viable cells of this line into
mice by the intracardiac or i.v. route
resulted in 1/10 and 5/10 mice, respec-
tively, developing grossly obvious mela-
noma colonies in the cerebrum by 3
weeks after injection. The tumour line
B16-Fl0-B2 was developed from a lesion
isolated from a single mouse afflicted with
a brain tumour after intracardiac injec-
tion. After isolation, the cell line was
allowed to grow in vitro until sufficient
numbers were available, when they were
frozen and stored in liquid N2. All com-
parisons between the cell lines were then
based on samples taken from these frozen
stocks at the same time. The results from
3 separate experiments examining the
in vivo behaviour of the cell lines are
presented in Table I. The i.v. injection
of an equal number of viable tumour cells
of the lines B16-F1O and B16-F10-B2
produced two very different metastatic
patterns. Of 27 mice injected with 5 x 104
BI 6-F10 cells, none developed brain
lesions, whereas 20/27 mice injected with
B16-F10-B2 cells had grossly obvious
brain tumours by 3 weeks from injection.
The line Bi 6-F10-B1 occupied an inter-
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TABLE I.-Metastatic behaviour of B16 melanoma variant lines*
Exp. 1 (male mice)
No. lung nodules: ine(lian (range)
No. mice witlh extrapulmonary
metastasis and location
(other tllan brain)
No. mice with gross brain ttumours
Exp. 2 (female mice)
No. lung nodules: medlian (range)
No. mice with extrapulmonary
metastasis and location
No. mice with gross brain tumours
E.Xp. 3 (male mice)
No. lutng nodules: median (range)
No. mice with extrapulmonary
metastasis and location
B16-FIO
39 (16-49)
4/10
3 testicle; 2 pancreas
0/10
49 (17-121)
4/7
ox aries
0/7
65 (36-128)
3/10
2 testicle; 1 pancreas
1 masseter muscle
No. mice wvitli gross brain tumouirs 0/10
Variant
B16-F10-BI B16-FIO-B2
234 (43-300)
4/10
testicle
2/9
> 300
6/10
4 testicle
1 adreinal
I lymplh node
4/10
> 300
4/9
testicle
7/9
B16-FIO-B3
> 300
5/9
testicle
6/9
> 300
8/8
ovaries
6/8
> 300
8/10
5 testicle
I adrenial; 1 ki(dney
1 pancreas
7/10
* Aice injecte(1 iv. cvi( the tail vein wxitlh 5 x 10-4 viable cells in 0-2 ml iioctulum (HBSS) andl necropsied 3
weeks later.
mediate position with regard tothenumber
ofmice developing brain tumours. Another
in vivo passage of B16-F1O-B2 cells to
produce the line B16-F1O-B3 did not
produce a noticeable change in metastatic
pattern; all further experiments used the
line B16-F10-B2. In order to rule out the
possibility that selection of brain-coloniz-
ing tumours was due to the residual, per-
manent effects of these drugs, the follow-
ing control experiment was performed.
FiG. 1.-Gross appearance of CNS metastases
in C57BL/6 mice 3 weeks after iv. injection
of B16-FIO-B2 cells.
Cells preincubated with cytochalasin B
and colchicine were maintained in tissue
culture for 2 weeks. They were then
harvested and injected into 10 female and
10 male mice as detailed above. None of
the mice so treated developed any visible
brain tumours by 3 weeks after injection.
There were no differences between the
number of lung nodules after injection of
these cells and of an equal number of
BI6-FFO cells into 20 control animals.
In those mice developing brain tumours,
the gross lesions were obvious as small,
discrete black areas, generally 2-3 per
mouse, diffusely scattered throughout the
dorsal cerebrum (Fig. 1). Histological
examination revealed that these black
areas were composed of small foci of mela-
noma cells, located predominantly on the
surface of the cerebral hemispheres; small
foci of tumour cells were found within the
white matter (Fig. 2) but metastases were
not seen in either the ventricles or the
choroid plexus. It appeared that initially
the cells were arrested and grew in the
meningeal blood vessels, and later expan-
ded and infiltrated into the brain paren-
chyma (Fig. 2). The Bl6-F1O-B2 line not
only gave significantly more lung nodules
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FiG. 2.-Histological section of brain (cerebrum) from syngeneic C57BL/6 mouse injected with 5 x 104
viable B16-FIO-B2 cells i.v. 3 weeks previously. (A) Lesion located on dorsal surface of cerebrum
wi'th coritiguous cord oftumour cellspenetrating into theparenchyma. (B) Arrows indicate isolated
foci of tumour cells within the brain parenchyma (x 56).
than the B16-FIO line (P,<0-001 by the
Mann-Whitney U test) but the morpho-
logical appearance ofthese tumour colonies
was markedly different (Fig. 3). Nodules
produced by the injection of B16-FIO
cells were uniformly deep black and
formed discrete lesions within the lung
parenchyma. Lung colonies obtained from
the B16-FIO-B2 line were so numerous
that they involved the whole lung, andA. RAZ AND I. R. HART
b
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FIG. 3.-Representative lungs fromC57BL/6 mice injected with 5 x 104cells of(a) B16-FIO cells and (b)
B16-F10-B2 cells. Differences are apparent between the number and melanin content ofthe tumour
colonies.
were a mixture of black and pearl-grey
colonies, and many of the nodules were
composed of a central dark core surroun-
ded by an opalescent grey circle (Fig. 3).
Three weeks after they were inoculated
with B16-F1O-B2 cells, mice generally
displayed no neurological signs. However,
when one group of 9 mice was allowed to
live over 3 weeks, they showed a high
incidence (7/9) of neurological disorders
associated with the formation of brain
tumours by 4 weeks after injection. These
neurological signs were blindness, hind-
leg paralysis, ataxia and staggering, circ-
ling and incoordination.
Stability of brain-colonizing variant
The B16-F1O-B2 cell line maintained its
brain-colonizing property after 4 months
of continuous tissue culture or 2 s.c.
passages in mice over a 2-month period,
TABLE II.-Distribution of 125IUdR-radiolabelled tumour cells in C57BL/6 mice
Time after i.v. injection
- _A
10 min
B16-F10 45,833 + 7,457*
92+ 15%
B16-FlO-B2 43,542 + 4,067
87+8%
B16-F1O 289 + 150
0-6+0.3%
B16-F10-B2 166+ 54
0.3+0 10%
60 min
38,969+ 2,086
78±4%
41,127 + 3,503
82±7%
477 + 69
09+0.-1%
398 + 108
08+08-2%
120 min
21,590+ 1,514
43+ 3%
32,287 + 2,814
65+6%
296 + 100
0-6+0-2%
498 + 216
1.0+0 4%
1 day
5,399 + 745
11+ 1/5%
16,075 + 1,700
-32±3%
174 + 28
0-3+0-06%
229 + 229
0.5+ 0.5%
* Number ofviable tumour cells remaining in organ after rinsing in ethanol. Mice were injected with 5 x 104
viable tumour cells i.v. via the tail vein. Five mice pZr sample were killed and the organs were treated as in
the text; results are expressed as mean + s.d.
a
(a) Lung
(b) Brain
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when injection of 50,000 viable tumour
cells produced gross brain metastases in
3/9 male mice and 5/6 female mice.
Quantitative analysi.s of tumour-cell arrest
and survival
This experiment was performed twice
with very similar results. Data from one
experiment are presented in Table II.
Tumour cells of the B16-FIO-B2 line
survived in the lungs to a greater extent
than B16-F10 cells (32°, vs 11% viable at
1 day) in spite of initial arrest being very
similar. Very few tumour cells localized in
the cranium (maximum of 10 by 2 h) but
there appeared to be no obvious difference
between the survival of B16-FIO and
BI 6-FI0-B2 cells at this site. There might
have been a trend for B16-F1O-B2 cells
to survive better than B16-Fl0 cells in
the cranium but, owing to the small
numbers ofcells involved and the difficulty
in evaluating them, the difference was not
significant.
100
x 1
(0
0) -J
E
z
10 20
Time After I.V. Injection (H)
Fia. 4.-Clearance rates of 125IUdR-labelled
tumour cells from the lungs of C57BL/6
mice. Data from one of two experiments
points represent means of 5 individual
animals (s.d. < 10%). B16-F1O (A);
B16-F1O-B2 (O).
The clearance of B16-FIO and B16-
F10-B2 from the lungs after i.v. injection
is shown in Fig. 4. The clearance of cells
from the lungs is biphasic, with initial
rapid clearance followed by a period of
slower removal. It is of interest that the
rate of B16-FIO-B2 clearance is slower
than that of B16-F1O cells in both phases
of the curve.
Karyotype analysis
The number and distribution ofchromo-
somes and the mean chromosome numbers
in the cells from the B16-FlO, B16-F1O-Bl
and B16-F1O-B2 melanoma cell lines are
represented in Fig. 5. The values were
based on 100 counts on each cell line. The
mean numbers of chromosomes were
68-9, 73-4 and 80-7 for B16-FIO, B16-
F10-BI and B16-Fl0-B2, respectively,
and the means of B16-F1O-B2 and B1]6-
FI0 were significantly different (P < 0 00l
Student's t test). Moreover, the variance
ofchromosomedistribution becamesmaller
with increasing selection (B16-FIO 386K1,
B16-F10-B1 345 7, B16-FlO-B2 301-8).
In vitro growth curves
No differences were seen among the 3
cell lines (B16-F1O, B16-F1O-B1 and
B16-F1O-B2) in their in vitro growth rates.
All 3 lines had population-doubling times
ofH-12h(Fig.6).
Cell morphology
Representative interference photomicro-
graplhs (Nomarski) are shown in Fig. 7.
The 4 different tumour cell lines are well
attached to the substratum and appear
bipolar. No gross differences in cellular
morphology could be detected among
any of the cell lines.
Cell-surface proteins
Exposed cell-surface proteins labelled
with 1251 by lactoperoxidase-catalyzed
iodination were separated by SDS-PAGE.
No major repeatable quantitative or quali-
tative differences in the relative expression
of a single protein were detected by our
techniques.
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FiG. 5. Histogram of chromosome number of B16 melanoma variants. Arrows represent the mean
of 100 cells.
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FIG. 6. In vitro growth curves of selected
melanoma lines. Means oftriplicate samples
(s.d. <5%). B16-F1O (0); B16-F1O-B1
(r01): B16-F1O-B2(A).
DISCUSSION
The present experiments describe the
development of a variant line of the B16
melanoma that is capable of colonizing
to the brain of recipient mice by 3 weeks
after i.v. inoculation.
It has been difficult to develop simple
models of metastatic brain tumours in
laboratory animals. The direct intracranial
inoculation oftumour cells ortransforming
agents cannot be considered analagous to
the systemic spread of disseminated dis-
ease (Rabson et al., 1974; Ausman et al.,
1970; Gershbein et al., 1975; Yung et al.,
1975; Conley & Remington, 1977; Rose-
man et at., 1978). Also, intracardiac or
intracarotid injections of tumour cells
(Ushio et al., 1977; Conley, 1979) require
greater technical expertise than i.v. inocu-
lation.
In order to initiate the selection pro-
cedure and obtain brain tumours, the first
B3
nn n rflmlllrill ni n
B2
n ri n n f rilrilrTfl n lThL mr Frrh n
_n n rm nm 1 11, n nMn 1114 n n
B16-F10
x
n m ~~ ~~rr1f~ln-rnf. i[lY fff1lII nIlFri, i-rm ri
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II
(. D1
FIG. 7. Interference photomicrograplhs (Nomarski) ofmonolayers of (A), B16-FIO; ancl variants (B),
BI; (C), B2 ani( (D), B3 (x 225).
B1 6 cells to be passaged were treated with
a combination of cytochalasin B and
colchicine at a level which had previously
been shown to increase extrapulmonary
metastasis from tumour-cell injection
(Hart & Fidler, 1980). Presumably this
modification of the tumour-cell cyto-
skeleton altered tumour-cell arrest pat-
terns and allowed a pre-existent cell, or
subpopulation of cells, to reach the brain
and develop there. Without this modifica-
tion, such cells might have been arrested
in the lungs and developed into lung
nodules indistinguishable from other such
tumour colonies. It is likely that in vitro
expansion of this subpopulation meant
that some cells from the injected suspen-
sion could avoid entrapment in the lungs
to develop into CNS metastases. The
evidence that subch brain-colonizing prop-
erties were not the result of the residual
effects of cytoskeleton-modifying drugs
supports this hypothesis. The achieve-
ment of a high degree of brain-colonizing
capacity after only 2 selection cycles (70-
75%0 animals involved) with stable pheno-
typic properties, and the failure ofa subse-
quent selection to enhance this effect,
suggest that the isolation of the B16-FIO-
B2 cell line resulted from selection rather
than adaptation. However, this remains
speculative since we have performed this
isolation procedure only once.
A change in chromosome number from
diploidy to aneuploidy has been implicated
in the progression ofsome tumours from a
benign to a malignant stage (Nowell,
1976). The karyotype analyses support
this interpretation, by showing a greater
mean chromosome number in the B1 6-
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F1O-B2 thanin the less metastatic parental
line. Moreover, the shift in chromosome
distribution towards a more homogeneous
one implies that the brain-seeking variant
may be composed of a relatively more
homogeneous cell population.
Metastatic heterogeneity among pre-
existent populations in the parental tu-
mour was first demonstrated clearly
with the B16 melanoma (Fidler & Kripke,
1977) and an increasing body of evidence
suggests that many other tumours are
also heterogeneous in metastatic capacity
(for review see Fidler et al., 1978; Hart &
Fidler, 1980). The isolation of different
variant lines from the same parental
tumour allows one to compare the proper-
ties likely to be important for metastatic
spread without referring to "normal cells",
a comparison ofdoubtful validity. Tumour
cell lines with preferential organ coloniza-
tion have been isolated previously from
the B16 melanoma (Brunson & Nicolson,
1979; Fidler, 1973; Tao et al., 1979)
including a line which preferentially seeks
brain tissue but not lung tissue (Brunson
et al., 1978). It would seem that the lines
established by us and by Brunson et al.
(1978) are markedly dissimilar in both
biological and cell-surface properties,
which may make the lines suitable for
different investigations. Differences in
properties are hardly surprising, since it
has been shown, by different isolation
techniques, that variants isolated from
the same parental population for the same
phenotype vary considerably in many
respects (Poste et al., 1980). It should be
emphasized that, in contrast to Brunson
et al. (1978) we have not isolated a
specifically brain-localizing tumour-cell
variant. Rather, the line we have isolated
is generally more metastatic with an in-
creased capacity for colonizing both lungs
and brain. It is of interest that although
the B16-F]0--B2 line produced an in-
creased incidence ofextrapulmonary meta-
stases, this increase was not of the same
magnitude as the increase in the incidence
of brain tumours. In our model, then, a
preferential localization of metastatic
deposits in brain tissue is similar to that
seen in cases of disseminated malignant
melanoma in man (Aronson et al., 1964;
Patel et al., 1978). Investigations are cur-
rently in progress in our laboratory to
attempt to determine those tumour and
host properties that allow these cells to
grow in the CNS.
This research was sponsored by the National
Cancer Institute under Contract No. NO1-CO-75380
withi Litton Bionetics, Inc.
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